Understanding relationships between autism, intelligence, and epilepsy: A cross-disorder approach

Developmental Medicine and Child Neurology

Volumn 55, Issue 2, 2013, Pages 146-153

  van Eeghen, Agnies M ^a,b   Pulsifer, Margaret B ^a   Merker, Vanessa L ^a   Neumeyer, Ann M ^a   van Eeghen, Elmer E ^a   Thibert, Ronald L ^a   Cole, Andrew J ^a   Leigh, Fawn A ^a   Plotkin, Scott R ^a   Thiele, Elizabeth A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; AUTISM; CHILD; CLINICAL FEATURE; COMORBIDITY; EPILEPSY; FEMALE; GENOTYPE; HUMAN; INTELLIGENCE; MAJOR CLINICAL STUDY; MALE; NEUROFIBROMATOSIS; NEUROFIBROMATOSIS TYPE 1; PRESCHOOL CHILD; PRIORITY JOURNAL; QUESTIONNAIRE; SCHOOL CHILD; TUBEROUS SCLEROSIS;

ADOLESCENT; AUTISTIC DISORDER; CHILD; CHILD, PRESCHOOL; EPILEPSY; FEMALE; HUMANS; INTELLIGENCE; MALE; PHENOTYPE; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; SOCIAL ADJUSTMENT; YOUNG ADULT;

EID: 84872535697     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/dmcn.12044     Document Type: Article

References (46)

1. Kelleher RJ , Bear MF. The autistic neuron: troubled translation?Cell 2008; 135: 401-6.
2. McDaniel SS, Wong M. Therapeutic role of mammalian target of rapamycin (mTOR) inhibition in preventing epileptogenesis. Neurosci Lett 2011; 3: 231-8.
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association, 2000.
4. Miles JH, Takahashi TN, Bagby S, et al.Essential versus complex autism: definition of fundamental prognostic subtypes. Am J Med Genet A 2000; 135: 171-80.
5. Goto J, Talos DM, Klein P, et al.Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complex. Proc Natl Acad Sci USA 2011; 108: E1070-9.
6. Cui Y, Costa RM, Murphy GG, et al.Neurofibromin regulation of ERK signaling modulates GABA release and learning. Cell 2008; 135: 549-60.
7. Gutierrez GC, Smalley SL, Tanguay PE. Autism in tuberous sclerosis complex. J Autism Dev Disord 1998; 28: 97-103.
8. Numis AL, Major P, Montenegro MA, Muzykewicz DA, Pulsifer MB, Thiele EA. Identification of risk factors for autism spectrum disorders in tuberous sclerosis complex. Neurology 2011; 76: 981-6.
9. Berg AT, Plioplys S, Tuchman R. Risk and correlates of autism spectrum disorder in children with epilepsy: a community-based study. J Child Neurol 2001; 26: 540-7.
10. Fombonne E, Du Mazaubrun C, Cans C, Grandjean H. Autism and associated medical disorders in a French epidemiological survey. J Am Acad Child Adolesc Psychiatry 1997; 36: 1561-9.
11. Ehninger D, Silva AJ. Genetics and neuropsychiatric disorders: treatment during adulthood. Nat Med 2009; 15: 849-50.
12. Lord C, Rutter M, Le Couteur A. Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 1994; 24: 659-85.
13. Lord C, Risi S, Lambrecht L, et al.The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord 2000; 30: 205-23.
14. Constantino JN, Gruber CP. Social Responsiveness Scale (SRS). Los Angeles, CA: Western Psychological Services, 2005.
15. Granader YE, Bender HA, Zemon V, Rathi S, Nass R, Macallister WS. The clinical utility of the Social Responsiveness Scale and Social Communication Questionnaire in tuberous sclerosis complex. Epilepsy Behav 2010; 18: 262-6.
16. Constantino JN, Todd RD. Intergenerational transmission of subthreshold autistic traits in the general population. Biol Psychiatry 2005; 57: 655-60.
17. Kwan P, Arzimanoglou A, Berg AT, et al.Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010; 51: 1069-77.
18. Berg AT, Hesdorffer DC, Zelko FA. Special education participation in children with epilepsy: what does it reflect?Epilepsy Behav 2011; 22: 336-41.
19. Berg AT, Plioplys S. Epilepsy and autism: is there a special relationship?Epilepsy Behav 2012; 23: 193-5.
20. Sevin JA, Bowers-Stephens C, Crafton CG. Psychiatric disorders in adolescents with developmental disabilities: longitudinal data on diagnostic disagreement in 150 clients. Child Psychiatry Hum Dev 2003; 34: 147-63.
21. Kanner L. Autistic disturbances of affective contact. Nerv Child 1943; 2: 217-50.
22. Constantino JN, Przybeck T, Friesen D, Todd RD. Reciprocal social behavior in children with and without pervasive developmental disorders. J Dev Behav Pediatr 2000; 21: 2-11.
23. Amiet C, Gourfinkel-An I, Bouzamondo A, et al.Epilepsy in autism is associated with intellectual disability and gender: evidence from a meta-analysis. Biol Psychiatry 2008; 64: 577-82.
24. Goh S, Kwiatkowski DJ, Dorer DJ, Thiele EA. Infantile spasms and intellectual outcomes in children with tuberous sclerosis complex. Neurology 2005; 65: 235-8.
25. Garcia-Nonell C, Ratera ER, Harris S, et al.Secondary medical diagnosis in fragile X syndrome with and without autism spectrum disorder. Am J Med Genet A 2008; 146A: 1911-6.
26. Eisermann MM, DeLaRaillere A, Dellatolas G, et al.Infantile spasms in Down syndrome - effects of delayed anticonvulsive treatment. Epilepsy Res 2003; 55: 21-7.
27. Cormack F, Cross JH, Isaacs E, et al.The development of intellectual abilities in pediatric temporal lobe epilepsy. Epilepsia 2007; 48: 201-4.
28. Auerbach BD, Osterweil EK, Bear MF. Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature 2011; 480: 63-8.
29. Talos DM, Sun H, Zhou X, et al.The interaction between early life epilepsy and autistic-like behavioral consequences: a role for the mammalian target of rapamycin (mTOR) pathway. PLoS ONE 2012; 7: e35885.
30. van Eeghen A, Black M, Pulsifer M, Kwiatkowski D, Thiele E. Genotype and cognitive phenotype in patients with tuberous sclerosis complex. Eur J Hum Genet 2012; 20: 510-5.
31. Descheemaeker MJ, Roelandts K, De Raedt T, Brems H, Fryns JP, Legius E. Intelligence in individuals with a neurofibromatosis type 1 microdeletion. Am J Med Genet A 2004; 131: 325-6.
32. Mautner VF, Kluwe L, Friedrich RE, et al.Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions. J Med Genet 2010; 47: 623-30.
33. Plank SM, Copeland-Yates SA, Sossey-Alaoui K, et al.Lack of association of the (AAAT)6 allele of the GXAlu tetranucleotide repeat in intron 27b of the NF1 gene with autism. Am J Med Genet 2001; 105: 404-5.
34. Leblond CS, Heinrich J, Delorme R, et al.Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders. PLoS Genet 2012; 8: e1002521.
35. Qin W, Chan JA, Vinters HV, et al.Analysis of TSC cortical tubers by deep sequencing of TSC1, TSC2 and KRAS demonstrates that small second-hit mutations in these genes are rare events. Brain Pathol 2010; 20: 1096-105.
36. Carcani-Rathwell I, Rabe-Hasketh S, Santosh PJ. Repetitive and stereotyped behaviours in pervasive developmental disorders. J Child Psychol Psychiatry 2006; 47: 573-81.
37. Pulsifer MB, Winterkorn EB, Thiele EA. Psychological profile of adults with tuberous sclerosis complex. Epilepsy Behav 2007; 10: 402-6.
38. Jackson MJ, Turkington D. Depression and anxiety in epilepsy. J Neurol Neurosurg Psychiatry 2005; 76: 45-7.
39. Hagerman RJ. Lessons from fragile X regarding neurobiology, autism, and neurodegeneration. J Dev Behav Pediatr 2006; 27: 63-74.
40. Constantino JN, Zhang Y, Frazier T, Abbacchi AM, Law P. Sibling recurrence and the genetic epidemiology of autism. Am J Psychiatry 2010; 167: 1349-56.
41. Hermann B, Meador KJ, Gaillard WD, Cramer JA. Cognition across the lifespan: antiepileptic drugs, epilepsy, or both?Epilepsy Behav 2010; 17: 1-5.
42. Rasmussen P, Borjesson O, Wentz E, Gillberg C. Autistic disorders in Down syndrome: background factors and clinical correlates. Dev Med Child Neurol 2001; 43: 750-4.
43. Molloy CA, Murray DS, Kinsman A, et al.Differences in the clinical presentation of Trisomy 21 with and without autism. J Intellect Disabil Res 2009; 53: 143-51.
44. Trillingsgaard A, Ostergaard JR. Autism in Angelman syndrome: an exploration of comorbidity. Autism 2004; 8: 163-74.
45. Payne JM, Moharir MD, Webster R, North KN. Brain structure and function in neurofibromatosis type 1: current concepts and future directions. J Neurol Neurosurg Psychiatry 2010; 81: 304-9.
46. Ridler K, Suckling J, Higgins NJ, et al.Neuroanatomical correlates of memory deficits in tuberous sclerosis complex. Cereb Cortex 2007; 17: 261-71.